Scope of the Drug Discovery Informatics Market
The research report categorizes the global Drug Discovery Informatics Market into the following segments and sub segments:
-
By Process
- Sequencing and Target Data Analysis
- Docking
- Molecular Modelling
- Libraries & Database Preparation
- Other Processes (Screening and ADMET characterization)
-
By Solution
- Software
- Services
-
By End User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Others (Academic Institutes, Government Organizations)
The key players in the drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the global market
North America is expected to account for the largest share of the global drug discovery informatics market.
Asia Pacific is expected to register the highest growth rate from 2017 to 2022. This can be attributed to the fastest-growing APAC pharmaceutical market in the world, the availability of many qualified researchers, and the low cost of human resources and manufacturing.
To Know More @ https://www.marketsandmarkets.com/Market-Reports/drug-discovery-informatics-market-64537381.html
